PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 175 filers reported holding PRECIGEN INC in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,554,124 | +21.4% | 1,094,454 | -1.7% | 0.00% | – |
Q2 2023 | $1,280,250 | +2.7% | 1,113,261 | -5.3% | 0.00% | – |
Q1 2023 | $1,246,062 | -10.9% | 1,175,531 | +27.7% | 0.00% | – |
Q4 2022 | $1,399,131 | -27.6% | 920,481 | +1.0% | 0.00% | – |
Q3 2022 | $1,932,000 | +53.7% | 911,441 | -2.8% | 0.00% | – |
Q2 2022 | $1,257,000 | -35.3% | 937,402 | +1.9% | 0.00% | – |
Q1 2022 | $1,942,000 | -45.2% | 920,275 | -3.7% | 0.00% | -100.0% |
Q4 2021 | $3,545,000 | -26.6% | 955,431 | -1.3% | 0.00% | 0.0% |
Q3 2021 | $4,830,000 | -26.3% | 967,887 | -3.7% | 0.00% | 0.0% |
Q2 2021 | $6,550,000 | +13.6% | 1,004,668 | +20.1% | 0.00% | 0.0% |
Q1 2021 | $5,766,000 | -30.3% | 836,807 | +3.2% | 0.00% | -50.0% |
Q4 2020 | $8,267,000 | +190.9% | 810,498 | -0.2% | 0.00% | +100.0% |
Q3 2020 | $2,842,000 | -2.1% | 812,114 | +39.5% | 0.00% | 0.0% |
Q2 2020 | $2,904,000 | -9.1% | 582,057 | -38.1% | 0.00% | 0.0% |
Q1 2020 | $3,196,000 | – | 940,193 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Patient Capital Management, LLC | 11,243,560 | $12,930,093 | 0.72% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 3,333,468 | $3,833,488 | 0.36% |
First Washington CORP | 592,975 | $681,921 | 0.30% |
Fore Capital, LLC | 490,000 | $563,500 | 0.26% |
EMFO, LLC | 180,000 | $207,000 | 0.19% |
MSD Partners, L.P. | 960,000 | $1,104,000 | 0.10% |
SANDERS MORRIS HARRIS LLC | 325,000 | $373,750 | 0.08% |
Virtus ETF Advisers LLC | 87,692 | $100,846 | 0.06% |
XTX Topco Ltd | 263,046 | $302,503 | 0.05% |
CHIRON CAPITAL MANAGEMENT, LLC | 45,906 | $52,792 | 0.04% |